Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Meca-Lallana JE, Prieto González JM, Caminero Rodríguez AB, Olascoaga Urtaza J, Alonso AM, Durán Ferreras E, Espinosa R, Dotor J, Romera M, Ares Luque A, Pérez Ruiz D, Calles C, Hernández MA, Hervás García M, Mendoza Rodríguez A, Berdei Montero Y, Téllez N, Herrera Varó N, Sotoca J, Presas-Rodríguez S, Querol Gutierrez LA, Hervás Pujol M, Batlle Nadal J, Martín Ozaeta G, Gubieras Lillo L, Martínez Yélamos S, Ramió-Torrentà L, Mallada Frechin J, Belenguer Benavides A, Gascón-Giménez F, Casanova B, Landete Pascual L, Berenguer L, Navarro L, Gómez Gutierrez M, Durán C, Rodríguez Regal A, Álvarez E, García-Estévez DA, López Real AM, Llaneza González MA, Marzo Sola ME, Sánchez-Menoyo JL, Oterino A, Villaverde González R, Castillo-Triviño T, Álvarez de Arcaya A, Llarena C. Meca-Lallana JE, et al. Among authors: gascon gimenez f. Neurol Ther. 2023 Dec;12(6):2177-2193. doi: 10.1007/s40120-023-00557-7. Epub 2023 Oct 20. Neurol Ther. 2023. PMID: 37861931 Free PMC article.
Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.
Gascón-Giménez F, Alcalá C, Ramió-Torrentà L, Montero P, Matías-Guiu J, Gómez-Estevez I, Oreja-Guevara C, Gil-Perotín S, Blanco Y, Carcelén M, Quintanilla-Bordás C, Costa L, Villar LM, Martínez-Rodriguez JE, Domínguez JA, Calles C, González I, Sotoca J, Oterino A, Lucas-Jimenez C, Pérez-Miralles F, Casanova B. Gascón-Giménez F, et al. Front Neurol. 2023 Mar 7;14:1060696. doi: 10.3389/fneur.2023.1060696. eCollection 2023. Front Neurol. 2023. PMID: 36959824 Free PMC article.
Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series.
Quintanilla-Bordás C, Gascón-Gimenez F, Alcalá C, Payá M, Mallada J, Silla R, Carratalà-Boscà S, Gasque-Rubio R, Castillo J, Casanova B. Quintanilla-Bordás C, et al. Among authors: gascon gimenez f. Front Neurol. 2022 Apr 27;13:897275. doi: 10.3389/fneur.2022.897275. eCollection 2022. Front Neurol. 2022. PMID: 35572939 Free PMC article.
Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study).
Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón-Giménez F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Medrano N, Maurino J, Casanova B. Pérez-Miralles F, et al. Among authors: gascon gimenez f. Mult Scler Relat Disord. 2021 May;50:102860. doi: 10.1016/j.msard.2021.102860. Epub 2021 Feb 23. Mult Scler Relat Disord. 2021. PMID: 33647591
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis.
Villarrubia N, Rodríguez-Martín E, Alari-Pahissa E, Aragón L, Castillo-Triviño T, Eixarch H, Ferrer JM, Martínez-Rodríguez JE, Massot M, Pinto-Medel MJ, Prada Á, Rodríguez-Acevedo B, Urbaneja P, Gascón-Gimenez F, Herrera G, Hernández-Clares R, Salgado MG, Oterino A, San Segundo D, Cuello JP, Gil-Herrera J, Cámara C, Gómez-Gutiérrez M, Martínez-Hernández E, Meca-Lallana V, Moga E, Muñoz-Calleja C, Querol L, Presas-Rodríguez S, Teniente-Serra A, Vlagea A, Muriel A, Roldán E, Villar LM. Villarrubia N, et al. Clin Chim Acta. 2019 Jan;488:135-142. doi: 10.1016/j.cca.2018.11.008. Epub 2018 Nov 5. Clin Chim Acta. 2019. PMID: 30408481
Brain region volumes and their relationship with disability progression and cognitive function in primary progressive multiple sclerosis.
Pérez-Miralles FC, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón-Giménez F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Carreres-Polo J, Casanova B. Pérez-Miralles FC, et al. Among authors: gascon gimenez f. Brain Behav. 2021 Apr;11(4):e02044. doi: 10.1002/brb3.2044. Epub 2021 Jan 23. Brain Behav. 2021. PMID: 33486890 Free PMC article.
CSF chitinase 3-like-1 association with disability of primary progressive MS.
Pérez-Miralles F, Prefasi D, García-Merino A, Gascón-Giménez F, Medrano N, Castillo-Villalba J, Cubas L, Alcalá C, Gil-Perotín S, Gómez-Ballesteros R, Maurino J, Álvarez-García E, Casanova B. Pérez-Miralles F, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Jul 1;7(5):e815. doi: 10.1212/NXI.0000000000000815. Print 2020 Sep. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32611760 Free PMC article.
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS.
Fernández-Velasco JI, Kuhle J, Monreal E, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Sánchez P, Carreón-Guarnizo E, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, Masjuan J, Costa-Frossard L, Villar LM. Fernández-Velasco JI, et al. Among authors: gascon gimenez f. Neurol Neuroimmunol Neuroinflamm. 2021 Jan 6;8(2):e940. doi: 10.1212/NXI.0000000000000940. Print 2021 Mar 4. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 33408167 Free PMC article.
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Fernández-Velasco JI, Monreal E, Kuhle J, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Oreja-Guevara C, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Lapuente-Suanzes P, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Diaz-Pérez C, Valero-López G, Diaz-Diaz J, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, García-Domínguez JM, Sabin J, Llufriu S, Masjuan J, Costa-Frossard L, Villar LM. Fernández-Velasco JI, et al. Among authors: gascon gimenez f. Front Immunol. 2022 Mar 21;13:842354. doi: 10.3389/fimmu.2022.842354. eCollection 2022. Front Immunol. 2022. PMID: 35386690 Free PMC article.
15 results